Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Jazz Pharma Plc
(NQ:
JAZZ
)
114.24
+3.28 (+2.96%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Jazz Pharma Plc
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
10 Biggest Price Target Changes For Monday
December 20, 2021
JP Morgan raised the price target on Public Storage (NYSE:
Via
Benzinga
The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More
December 17, 2021
Below is a recap of the main news related to the cannabis industry and markets for the week of December 13, 2021.
Via
Benzinga
10 Biggest Price Target Changes For Friday
December 17, 2021
Piper Sandler boosted Accenture plc (NYSE:ACN) pric...
Via
Benzinga
7 Meme Stocks to Buy on Their Market Slump and Rebound
December 14, 2021
These seven meme stocks suffered downturns recently, but they have the appropriate catalysts to move upward in the near term.
Via
InvestorPlace
Are Cannabinoids the Next Frontier of Pharmaceuticals? This Company Thinks So and Wants to Lead the Pack
December 14, 2021
Photo by Michael Longmire on...
Via
Benzinga
How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal
December 13, 2021
The two publicly-traded companies confirmed Monday that they have signed a definitive agreement under which Pfizer will acquire all outstanding shares of Arena for $100 per share in an all-cash...
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal
December 13, 2021
Pharmaceutical giant Pfizer Inc. (NYSE:PFE) is e...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Jazz Posts New Data for ALL/LBL Treatment At ASH 2021 Annual Meeting
December 13, 2021
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) revealed initial positive results from a Phase 2/3 trial of intramuscular (IM) administration of Rylaze (asparaginase...
Via
Benzinga
Jupiter Wellness Just Reported A Big Move In Pharma
December 10, 2021
Image provided by Jupiter Wellness of their new lab. The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content...
Via
Benzinga
3 High-Growth Stocks That Are Screaming Buys in December
December 09, 2021
Now is a good time to be greedy and buy up these depressed stocks.
Via
The Motley Fool
Got $5,000? Buy These 3 Hot Pot Stocks Immediately
November 27, 2021
There might not be a better time to buy these three cannabis stocks than right now.
Via
The Motley Fool
Topics
Cannabis
Exposures
Cannabis
EXCLUSIVE: Cannabis-Based Drug Approved For Cancer Treatment In Peru
November 22, 2021
Cannabis-based drug Sativyl has been approved as a treatment for cancer-related pain in Peru.
Via
Benzinga
2 Top Marijuana Stocks to Buy for the Long Haul
November 21, 2021
If you're patient with these investments, they can produce great returns for your portfolio.
Via
The Motley Fool
Topics
Cannabis
Exposures
Cannabis
Better Buy: Compass Pathways vs. Jazz Pharmaceuticals
November 21, 2021
Both of these biotech stocks are innovators, but one is more likely to hit it out of the park.
Via
The Motley Fool
The Week In Cannabis: Earnings Season, A GOP Legalization Bill, Seth Rogen & Sarah Silverman's Campaign
November 12, 2021
Below is a recap of the main news related to the cannabis industry and markets for the week of November 8, 2021.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
7 F-Rated Stocks to Sell Before We Reach Christmas
November 10, 2021
It's just as important to know what stocks to sell as it is to know what stocks to buy. These stocks are prime examples of stocks to drop now.
Via
InvestorPlace
Jazz Pharmaceuticals PLC (JAZZ) Q3 2021 Earnings Call Transcript
November 10, 2021
JAZZ earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Jazz Pharmaceuticals Reports Q3 Financial Results, Raises Full-Year Earnings Guidance
November 09, 2021
Jazz Pharmaceuticals plc (NASDAQ:JAZZ), a global biopharma...
Via
Benzinga
Jazz Pharmaceuticals: Q3 Earnings Insights
November 09, 2021
Jazz Pharmaceuticals (NASDAQ: JAZZ) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement....
Via
Benzinga
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
Lexaria Announces DehydraTECH-CBD Versus Prescription CBD Program In Treating Seizures
November 01, 2021
Lexaria Bioscience Corp (NASDAQ: LEXX) has commenced a new study to compare the effectiveness of Epidiolex to DehydraTECH-cannabidiol (CBD) for reducing seizure...
Via
Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
2 Top Growth Stocks to Buy Heading Into November
October 30, 2021
There's plenty of growth on the horizon for these stocks, which are trading near their lows for the year.
Via
The Motley Fool
Jim Cramer Considers nCino As Winner, Prefers This Stock Over Perficient
October 27, 2021
On CNBC’s "Mad Money ...
Via
Benzinga
Leading the Charge to Develop the First Orexin-Targeted Therapy to Address Narcolepsy at its Root Cause
October 20, 2021
Photo by MART PRODUCTION from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
SEC Charges Former Goldman Sachs Officer For Insider Trading On 2 M&A Deals
October 01, 2021
The Securities and Exchange Commission has charged a former Goldman Sachs (NYSE: GS) compliance analyst with using confidential information to generate over $...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021
October 05, 2021
Upgrades Wolfe Research upgraded the previous rating for PACCAR Inc (NASDAQ:
Via
Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.